Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-005842-35-IT
EUCTR2006-005842-35-IT
Active, not recruiting
Not Applicable

Efficacy and safety of treatment with N-butyl-deoxynojirimycin (NB-DNJ-miglustat) in patients with Niemann-Pick disease type C. - ND

Dipartimento di Pediatria Universita` di Napoli Federico II0 sitesOctober 28, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsZAVESCA

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Dipartimento di Pediatria Universita` di Napoli Federico II
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 28, 2009
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Dipartimento di Pediatria Universita` di Napoli Federico II

Eligibility Criteria

Inclusion Criteria

  • •Diagnosis of NPC confirmed by biochemical tests (filipin staining and LDL\-cholesterol esterification) and/or molecular analysis
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Patients unable to take the drug Bad compliance to study procedures Patients with renal failure Fertile women that do not consent to oral contraceptives during the study and until three months after discontinuation of treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical Research on the Efficacy of Bosinji on Low Back Pain and Radiculopathy by Herniated Intervertebral Disc of Lumbar SpineDiseases of the musculo-skeletal system and connective tissue
KCT0002848Kyung Hee University74
Completed
Phase 4
Effectiveness and safety of bromocriptine when it is combined with metformin in Indian patients with type II diabetes mellitusHealth Condition 1: null- Moderate cases of type II diabetes mellitusHealth Condition 2: E119- Type 2 diabetes mellitus without complications
CTRI/2012/05/002659Dr Nilanjan Sengupta60
Completed
Phase 1
Botulinum toxin-loaded detachable dissolvable microneedles for primary axillary hyperhidrosis: A pilot study on efficacy and safetyaxillary sweatingMicroneedle Transdermal Botulinum Toxin Botox Patch test
TCTR20201230002Material and Bio interface10
Not yet recruiting
Not Applicable
Treatment of primary palmar hyperhidrosisSkin and Connective Tissue Diseases
PACTR202006915898923Mansoura university faculty of medicine80
Not yet recruiting
Phase 4
Evaluating the efficacy and safety of (Embella®) in management of superficial lipomassuperficial lipoma.Benign lipomatous neoplasm
IRCT20240416061507N2Espad pharmed10